| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 9.84M | — |
| Operating expense | — | — |
| Net income | -38.53M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, STRO returned +144.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +81.8% |
| 1 year | +144.7% |
| 5 years | -90.3% |
| All-time high | $227.60 (Mar 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in STRO would be worth today ›No. Sutro Biopharma, Inc. has not paid a dividend in the past 12 months.
Sutro Biopharma, Inc. stock trades on NASDAQ under the ticker symbol STRO.
Sutro Biopharma, Inc. is part of the Healthcare sector.
Sutro Biopharma, Inc. has a market cap of 348.87M USD, based on the latest quote.
